Opaleye Management reports $124,453 Grace Therapeutics common share purchase
GRCE•Opaleye Management, a 10% owner of Grace Therapeutics, bought 60,490 shares for $124,453 in open-market transactions. Its reported ownership rose to 2,858,657 shares, held indirectly through Opaleye, L.P.
1. Share purchase
Opaleye Management added 60,490 Grace Therapeutics shares through open-market purchases at weighted-average prices of $2.0353, $2.0684 and $2.06. The purchases brought its reported ownership to 2,858,657 shares, held indirectly through Opaleye, L.P.
